In a nutshell This study investigated the effect of exenatide (EXE; Byetta) on kidney function, obesity and glucose control in overweight or obese patients with type 2 diabetes (T2D). The data showed that EXE could assist in improving kidney function, glucose control, and inflammation after 24 weeks of treatment. Some background Diabetic...
Read More
In a nutshell This review looked at how SGTL2 inhibitors with or without metformin (Glucophage) affect heart and kidney health for patients with type 2 diabetes (T2D). It found that these medications improve cardiovascular and kidney outcomes, whether or not patients are also taking metformin. Some background SGLT2 inhibitors are a group of T2D...
Read More
In a nutshell This study looked at exenatide (Byetta) for patients with type 2 diabetes (T2D) and kidney damage. It found that exenatide may reduce kidney damage compared to other diabetes treatments. Some background T2D is a disorder in which the body does not respond well to the hormone insulin. This causes high levels of glucose (sugar) in the...
Read More
In a nutshell This study investigated the long-term effects of ipragliflozin (Suglat) in people with type 2 diabetes (T2D). It was determined that ipragliflozin showed long-term beneficial effects on blood glucose control, weight, and kidney function. Some background Ipragliflozin is an SGLT2 inhibitor. SGLT2 inhibitors are medications for T2M that...
Read More
In a nutshell This study examined if Omega-3 fatty acid supplementation could improve kidney function in patients with diabetes and hypertriglyceridemia. They found that a daily dose of 4 grams of Omega-3 fatty acids improved kidney function in these diabetic patients. Some background A common complication of diabetes is kidney disease. If it is...
Read MoreIn a nutshell This study compared the effectiveness and safety of two drugs in the treatment of type 2 diabetes patients with kidney disease. Some background Type 2 diabetes (T2D) is characterized by elevated blood glucose. Treatment involves lowering blood glucose. HbA1c (average blood glucose over 3 months) and fasting plasma glucose (FPG,...
Read More
In a nutshell This study examined the use of liraglutide (Victoza) in patients with type 2 diabetes plus end-stage renal disease. Some background Patients with type 2 diabetes do not produce enough or are resistant to insulin, the hormone necessary to break down the glucose (sugar) taken in from food. This insensitivity to insulin can lead to high...
Read More
In a nutshell This study evaluated the relationship between high serum uric acid (SUA) levels and atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM). Some background Uric acid is a compound normally produced in the body and normally filtered out of the blood by the kidneys. High levels of uric acid in the blood...
Read MoreIn a nutshell The aim of the Look AHEAD (Action for Health in Diabetes) study was to asses the effect of an intensive lifestyle intervention on the body weight, fitness and mobility of overweight patients with type 2 diabetes (T2DM). Some background According to the Centers for Disease Control and Prevention more people may suffer from T2DM...
Read More
